Switzerland Novartis Invest 23bn in US production and R & D


Unlock free digitter digestive

Swiss Group of Swiss Novartis said it would have said that it will expand US investment and development of the preparation for potential tariffs.

Novartis, which makes cancer from cancer of cardiovascular, investment saying it can produce all our doses. It will create seven new places and grow others.

Vas Narasiman, the chief executive head of NovartisInvestment says « Environment Policy and Environment in the United States that supports our ability to seek medical advancement to patients.

The announcement is the latest US investment by a large drug company since Donald Trump has received a presidential election. Eli Indianapolis-based Eli Lilly announced Plan in investment in $ 27BN In February, while Johnson & Johnson, which has a headquarters in New Jersey, says last month to invest in 4 plants. Astrazeeca said in November that it will invest $ 3.5bn in the US.

Have Pharmaceutical industry Been exempt from the World Customs Agency declared by Trump last week. But the administration has symbolic that they will force soon.

Novartis estimates that investment will create nearly 1,000 jobs at the company, and 4,000 in the supply chain and community. It will also invest in producing the ingredient in the US medicine, is a detailed area in China and India.

The company will establish the research and development and development in San Diego $ 1.1bn, it is secondary of the United States of America after its place in Boston. It will open the manufacturer for radiolandand treatment, in Florida and Texas, and the factory expansion in Indiana, New Jersey, New Jersey and California.

Naramaman said the company was « ready for a change in an external environment » and « confidence in the middle of the year in 2027.



Source link

Leave a Reply

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *